These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 15598856)
1. Infant immunization and family size. Reading R; Surridge H; Adamson R J Public Health (Oxf); 2004 Dec; 26(4):369-71. PubMed ID: 15598856 [TBL] [Abstract][Full Text] [Related]
2. The two-dose measles, mumps, and rubella (MMR) immunisation schedule: factors affecting maternal intention to vaccinate. Pareek M; Pattison HM Br J Gen Pract; 2000 Dec; 50(461):969-71. PubMed ID: 11224968 [TBL] [Abstract][Full Text] [Related]
3. Combination vaccine use and vaccination quality in a managed care population. Happe LE; Lunacsek OE; Marshall GS; Lewis T; Spencer S Am J Manag Care; 2007 Sep; 13(9):506-12. PubMed ID: 17803364 [TBL] [Abstract][Full Text] [Related]
5. Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations. Fombonne E; Zakarian R; Bennett A; Meng L; McLean-Heywood D Pediatrics; 2006 Jul; 118(1):e139-50. PubMed ID: 16818529 [TBL] [Abstract][Full Text] [Related]
6. How do physicians immunize their own children? Differences among pediatricians and nonpediatricians. Posfay-Barbe KM; Heininger U; Aebi C; Desgrandchamps D; Vaudaux B; Siegrist CA Pediatrics; 2005 Nov; 116(5):e623-33. PubMed ID: 16263976 [TBL] [Abstract][Full Text] [Related]
7. Coverage of recommended vaccines in children at 7-8 years of age in Flanders, Belgium. Theeten H; Vandermeulen C; Roelants M; Hoppenbrouwers K; Depoorter AM; Van Damme P Acta Paediatr; 2009 Aug; 98(8):1307-12. PubMed ID: 19432835 [TBL] [Abstract][Full Text] [Related]
8. Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children. France EK; Glanz J; Xu S; Hambidge S; Yamasaki K; Black SB; Marcy M; Mullooly JP; Jackson LA; Nordin J; Belongia EA; Hohman K; Chen RT; Davis R; Pediatrics; 2008 Mar; 121(3):e687-92. PubMed ID: 18310189 [TBL] [Abstract][Full Text] [Related]
9. Vaccination rates in a multicultural population. van der Wal MF; Diepenmaat AC; Pel JM; Hirasing RA Arch Dis Child; 2005 Jan; 90(1):36-40. PubMed ID: 15613508 [TBL] [Abstract][Full Text] [Related]
10. Case-control study of vaccination history in relation to pertussis risk during an outbreak among school students. Khan FN; Lin M; Hinkle CJ; Franklin P; Luther R; Woodruff F; Henson K; Lukenbill M; Gutierrez M; Zhu BP Pediatr Infect Dis J; 2006 Dec; 25(12):1132-6. PubMed ID: 17133158 [TBL] [Abstract][Full Text] [Related]
11. Humoral and cellular immune response after measles vaccination in Taiwan. Huang CL; Yang YH; Wang LC; Lin YT; Tsai YY; Chiang BL J Microbiol Immunol Infect; 2005 Jun; 38(3):169-75. PubMed ID: 15986066 [TBL] [Abstract][Full Text] [Related]
12. Could the MMR vaccine replace the measles vaccine at one year of age in Egypt? Abbassy AA; Barakat SS; Abd El Fattah MM; Said ZN; El Metwally HA East Mediterr Health J; 2009; 15(1):85-93. PubMed ID: 19469430 [TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age. Gustafsson L; Hessel L; Storsaeter J; Olin P Pediatrics; 2006 Sep; 118(3):978-84. PubMed ID: 16950988 [TBL] [Abstract][Full Text] [Related]
14. Assessment of delay in age-appropriate vaccination using survival analysis. Dayan GH; Shaw KM; Baughman AL; Orellana LC; Forlenza R; Ellis A; Chaui J; Kaplan S; Strebel P Am J Epidemiol; 2006 Mar; 163(6):561-70. PubMed ID: 16421238 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy. Sultana R; Rahman MM; Hassan Z; Hassan MS Scand J Immunol; 2006 Dec; 64(6):684-9. PubMed ID: 17083626 [TBL] [Abstract][Full Text] [Related]
16. [Assessment of primary care physicians' adherence to the national childhood vaccination schedule]. Pruvost I; Lowingerova-Fauvet S; Debacker P; Dervaux B; Dubos F; Martinot A Arch Pediatr; 2012 Mar; 19(3):248-53. PubMed ID: 22264997 [TBL] [Abstract][Full Text] [Related]
17. Socio-demographic and health-related predictors of uptake of first MMR immunisation in the Lifeways Cohort Study. Jessop LJ; Murrin C; Lotya J; Clarke AT; O'Mahony D; Fallon UB; Johnson H; Bury G; Kelleher CC; Murphy AW; Vaccine; 2010 Aug; 28(38):6338-43. PubMed ID: 20637302 [TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and safety of measles-mumps-rubella, varicella and Haemophilus influenzae type b vaccines administered concurrently with a fourth dose of heptavalent pneumococcal conjugate vaccine compared with the vaccines administered without heptavalent pneumococcal conjugate vaccine. Black SB; Cimino CO; Hansen J; Lewis E; Ray P; Corsaro B; Graepel J; Laufer D Pediatr Infect Dis J; 2006 Apr; 25(4):306-11. PubMed ID: 16567981 [TBL] [Abstract][Full Text] [Related]
19. Impact of a decline in Colorado Medicaid managed care enrollment on access and quality of preventive primary care services. Berman S; Armon C; Todd J Pediatrics; 2005 Dec; 116(6):1474-9. PubMed ID: 16322173 [TBL] [Abstract][Full Text] [Related]
20. Parental refusal of pertussis vaccination is associated with an increased risk of pertussis infection in children. Glanz JM; McClure DL; Magid DJ; Daley MF; France EK; Salmon DA; Hambidge SJ Pediatrics; 2009 Jun; 123(6):1446-51. PubMed ID: 19482753 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]